Search
for
Sort by
Research 211–240 of 1000+
- Ruxolitinib found to cause eyelash growth: a case report
- Permanent chemotherapy-induced alopecia after hematopoietic stem cell transplantation treated with low-dose oral minoxidil
- Resolution of refractory generalized granuloma annulare after treatment with alitretinoin
- The ophthalmological complications of targeted agents in cancer therapy: what do we need to know as ophthalmologists?
- Cancer Chemotherapy: an Introduction
- Biological Potential and Therapeutic Effectiveness of Hinokiflavone in Medicine: The Effective Components of Herbal Medicines for Treatment of Cancers and Associated Complications
- Mucocutaneous findings in hematolymphoid neoplasms: An observational study
- The role of WNT10B in physiology and disease: A 10-year update
- Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumours
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- Unraveling Translational Insights into Systemic Multi-Organ Toxicity of Cytosine Arabinoside (Ara-C): A Systematic Review of Preclinical Animal Evidence
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Does Severity of Hair Loss Matter? Factors Associated with Mental Health Outcomes in Women Irradiated for Tinea Capitis in Childhood
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Cutaneous extramedullary haematopoiesis: Implications in human disease and treatment
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Food Bioactive Compounds and Emerging Techniques for Their Extraction: Polyphenols as a Case Study
- Clinical and Immunological Phenotype of Patients With Primary Immunodeficiency Due to Damaging Mutations in NFKB2
- Effects of microenvironment and biological behavior on the paracrine function of stem cells
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
- Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma
- JAK inhibition decreases the autoimmune burden in Down syndrome
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- Cell death in skin function, inflammation, and disease
- Skin manifestations associated with systemic diseases – Part I
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib